Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 4/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | HTR5A | P47898 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14627593 | 0.82 | SLC6A4 (0.48) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C | |
| SCHEMBL13877239 | 0.82 | SLC6A4 (0.43) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C | |
| SCHEMBL14595413 | 0.81 | SLC6A4 (0.42) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C | |
| SCHEMBL13877241 | 0.81 | SLC6A4 (0.47) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C | |
| SCHEMBL11822161 | 0.75 | CYP1A2 (0.47) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C | |
| SCHEMBL20200994 | 0.74 | SLC6A4 (0.42) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C | |
| SCHEMBL3858428 | 0.73 | MCHR1 (0.52) | SLC6A4CYP1A2CYP2D6TSHR | |
| SCHEMBL14363772 | 0.73 | SLC6A4 (0.43) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C | |
| SCHEMBL20635520 | 0.72 | HDAC6 (0.47) | SLC6A4ALDH1A1TSHR | |
| SCHEMBL8793251 | 0.72 | HTR2A (0.44) | SLC6A4CYP1A2CYP2D6HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9523031-B2 | Organic electroluminescent device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-20 | — | — | US | disclosed |
| US-9523031-B2 | Organic electroluminescent device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-20 | — | — | US | disclosed |
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20070224448-A1 | Organic Electroluminescent Device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070224448-A1 | Organic Electroluminescent Device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070190355-A1 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070190355-A1 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070009760-A1 | Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device | INOUE TETSUYA | 2007-01-11 | — | — | US | disclosed |
| US-20070009760-A1 | Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device | INOUE TETSUYA | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | INTS9, KCNN2, KCNH3 | SLC6A4 2552/4885CYP1A2 1307/4885CYP2D6 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.